6
Oct
2026
ABDI IBRAHIM ILAC SAN. VE TIC. A.S.
Exhibitor at CPHI Milan 2026 stand 7H17, Integrated Pharma
About Us
Categories
-
Country/Region:Türkiye
-
On CPHI since:2015
-
Certificates:3
-
Employees:5000+
Company types
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 7H17, Integrated Pharma
Products Featured at CPHI Milan 2026
-
Product DICLOFENAC /50 mg Tablet
Non-Steroidal Antirheumatics -
Product ACETYLSALICYLIC ACID /100 mg Enteric Coated Tablet
Platelet aggregation inhibitors (COX inhibitors) -
Product OLANZAPINE /2.5 mg & 5 mg & 10 mg & 20 mg Tablet
Atypical Antipsychotics - Schizophrenia -
Product FLUTICASONE + SALMETEROL /50 mcg/100mcg Dry Powder Inhaler
Adrenergics (B2 agonists) in combination with corticosteroids - Asthma & COPD -
Product LEVOTHYROXINE SODIUM /25mcg; 50mcg; 75mcg; 100mcg; 125mcg; 150mcg; 200mcg Tablet
Thyroid Preparations - Hypothyroidism
ABDI IBRAHIM ILAC SAN. VE TIC. A.S. Resources (1)
-
Brochure HEALING THE LIVES, HEALING THE FUTURE THAT’S WHAT WE DO.
Turkish pharmaceutical industry leader Abdi Ibrahim s journey began in 1912.In addition to its partnerships with more than 30 licensing firms across the globe, Abdi Ibrahim develops its own products with 250 brands and 500 products.Abdi Ibrahim has subsidiaries operating in 17 countries outside Turkey, exports to more than 70 countries from the European Union to Canada, North Africa to Asia and generates the highest employment rate in the Turkish pharmaceutical industry with 5500 qualified employees.
